Dr Ajithkumar Vasanthakumar

Head, Tissue and Tumour Immunity Laboratory

The ongoing objective of my work is to identify a mechanism that can be harnessed to target Tregs for cancer treatment.

After completing my PhD in Biotechnology I took up the opportunity to move to Australia to undertake my postdoc, initially at the Burnett Institute and then at Molecular Immunology division at the Walter and Eliza Hall Institute of Medical Research (WEHI) before becoming a Research Fellow at the Peter Doherty Institute.

It was at WEHI that I initiated studies on understanding how Tregs adapt to different tissues and made the landmark discovery that Tregs in adipose tissue require a growth factor called IL-33.

My research continues to be focused on investigating tissue specific homeostatic mechanisms of Tregs.